Partner Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Partner Investment Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,400	Closed	-$1.25M	–	69
2019 Q3	$1.25M	Buy	+16,400	New	+$1.36M	2.14%	16
2018 Q4	–	Sell	-5,300	Closed	-$508K	–	120
2018 Q3	$508K	Buy	+5,300	New	+$514K	0.39%	77
2018 Q1	–	Sell	-16,400	Closed	-$1.39M	–	96
2017 Q4	$1.39M	Buy	+16,400	New	+$1.37M	1.6%	23

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Partner Investment Management's XBI Position: Q4 2017 in Review

Partner Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2017, closing a stake of 10,792 shares — an estimated $904K sold.

Partner Investment Management first reported a position in XBI in Q4 2016 and held it in 2 quarters. The position peaked at $934K in Q3 2017. 397 funds tracked by Wall St. Rank hold XBI as of Q4 2017.

Partner Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2017 after selling out during the quarter.
Partner Investment Management sold 10,792 State Street SPDR S&P Biotech ETF shares in Q4 2017, an estimated $904K.
Partner Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 2 quarters.
Partner Investment Management's State Street SPDR S&P Biotech ETF position peaked at $934K in Q3 2017.
397 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2017.

Based on Partner Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.